Clinical trials in Westerstede

23 clinical trials in Westerstede, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in GermanyKlinischeStudien.de

Westerstede at a glance

clinical trials

Paediatric trials0
Research sites0

Quick filters

23 trials in Westerstede

Open in trial search

Chronic lymphocytic leukaemia+1

Recruiting

A Study Comparing BGB-16673 to Pirtobrutinib for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded

Registered drugNo placebo

A Study Comparing BGB-16673 to Pirtobrutinib for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:BGB-16673
Sponsor:BeOne Medicines AG

Contact Research Centre

Triple negative breast cancer

Recruiting

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

Registered drugNo placebo

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Dementia Alzheimer's type

Recruiting

Study on the Effects of Rotigotine and Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease

Registered drug

Study on the Effects of Rotigotine and Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Rotigotine
Sponsor:Fondazione Santa Lucia

Contact Research Centre

Hormone receptor positive breast cancer+2

Recruiting

Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

Registered drugNo placebo

Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:Institut Für Frauengesundheit GmbH

Contact Research Centre

Squamous cell carcinoma of lung+3

Not yet recruiting

Tislelizumab with drug combination in patients with PD-L1‑high metastatic non‑small cell lung cancer and high tumor burden

Registered drugNo placebo

Tislelizumab with drug combination in patients with PD-L1‑high metastatic non‑small cell lung cancer and high tumor burden

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:AIO-Studien gGmbH

Contact Research Centre

Nervous system disorder

Not yet recruiting

Continued Access Study for Patients with Neurological Disease Using Ocrelizumab and Drug Combination

Registered drugNo placebo

Continued Access Study for Patients with Neurological Disease Using Ocrelizumab and Drug Combination

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ocrelizumab
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Registered drug

Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Neuralgia+1

Not recruiting

Study on LY3848575 for Reducing Pain in Patients with Distal Sensory Polyneuropathy

Investigational

Study on LY3848575 for Reducing Pain in Patients with Distal Sensory Polyneuropathy

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:LY3848575
Sponsor:Eli Lilly & Co.

Contact Research Centre

Multiple sclerosis+1

Not recruiting

Study on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis

Registered drugNo placebo

Study on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Methylprednisolone
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Investigational

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Quinidine Sulfate
Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Contact Research Centre

Schizophrenia

Not recruiting

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

InvestigationalNo placebo

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

InvestigationalNo placebo

Germany

Participants:18–64 years
Substances:Iclepertin
Sponsor:Boehringer Ingelheim International GmbH

Contact Research Centre

Neuralgia

Not recruiting

Study on the Effectiveness and Safety of NT 201 Injections for Adults with Chronic Neuropathic Pain from Postherpetic Neuralgia or Nerve Injury

Registered drug

Study on the Effectiveness and Safety of NT 201 Injections for Adults with Chronic Neuropathic Pain from Postherpetic Neuralgia or Nerve Injury

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Paracetamol
Sponsor:Merz Therapeutics GmbH

Contact Research Centre

Other cities in Germany

The busiest research cities in the country

All 513 cities in Germany

Clinical research in Westerstede

What the registry says about research in the country

01 Neurological Disorders

Comprehensive research focusing on Multiple Sclerosis treatments and disease progression, including studies evaluating novel therapies like ocrelizumab and fenebrutinib for both progressive and relapsing forms.

Progressive Multiple Sclerosis
Relapsing Multiple Sclerosis
General Neurological Conditions

Studies aim to assess long-term safety and effectiveness of treatments while monitoring disease progression.

02 Migraine Research

Multiple trials investigating preventive treatments for various types of migraine conditions, including menstrual migraine and medication overuse headache, using innovative compounds like atogepant and eptinezumab.

Chronic Migraine
Menstrual Migraine
Medication Overuse Headache

Focus on both acute treatment and prevention strategies for migraine management.

03 Mental Health Studies

Extensive research into Major Depressive Disorder and Schizophrenia, evaluating new therapeutic approaches and long-term treatment options.

Depression Treatment
Cognitive Impairment
ADHD Management

Trials explore both novel compounds and combination therapies for improved patient outcomes.

04 Neurodegenerative Conditions

Focused studies on Alzheimer's Disease examining new treatment approaches for both early-stage disease and management of associated symptoms like agitation.

Early Alzheimer's Disease
Mild to Moderate Alzheimer's
Dementia-Related Agitation

Research encompasses both disease-modifying treatments and symptom management strategies.

Back to Germany All countries